Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9267)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2019 (publication date) through Jan 23, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tintelnot J, Stein A. Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches. World J Gastroenterol 2019; 25(29): 3920-3928 [PMID: 31413527 DOI: 10.3748/wjg.v25.i29.3920] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i29/3920.htm |
| Number | Citing Articles |
| 1 |
Manish R. Patel, Gerald S. Falchook, Kensuke Hamada, Lukas Makris, Johanna C. Bendell. A phase 2 trial of trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite‐stable metastatic colorectal cancer. Cancer Medicine 2021; 10(4): 1183 doi: 10.1002/cam4.3630
|
| 2 |
Sanjay Anand, Lauren E. Heusinkveld, Cheng‐En Cheng, Lefatshe Lefatshe, Pushpamali De Silva, Tayyaba Hasan, Edward V. Maytin. Combination of 5‐Fluorouracil with Photodynamic Therapy: Enhancement of Innate and Adaptive Immune Responses in a Murine Model of Actinic Keratosis†. Photochemistry and Photobiology 2023; 99(2): 437 doi: 10.1111/php.13706
|
| 3 |
Ebunoluwa E. Otegbeye, Jonathan B. Mitchem, Haeseong Park, Aadel A. Chaudhuri, Hyun Kim, Matthew G. Mutch, Matthew A. Ciorba. Immunity, immunotherapy, and rectal cancer: A clinical and translational science review. Translational Research 2021; 231: 124 doi: 10.1016/j.trsl.2020.12.002
|
| 4 |
Yu Takeda, Shogo Kobayashi, Masatoshi Kitakaze, Daisaku Yamada, Hirofumi Akita, Ayumu Asai, Masamitsu Konno, Takahiro Arai, Toru Kitagawa, Ken Ofusa, Masami Yabumoto, Takaaki Hirotsu, Andrea Vecchione, Masateru Taniguchi, Yuichiro Doki, Hidetoshi Eguchi, Hideshi Ishii. Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes. Cells 2020; 9(7): 1645 doi: 10.3390/cells9071645
|
| 5 |
Qingzhu Jia, Han Chu, Zheng Jin, Haixia Long, Bo Zhu. High-throughput single-сell sequencing in cancer research. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-00990-4
|
| 6 |
Rui He, Yefang Lao, Wenyan Yu, Xiaohui Zhang, Min Jiang, Chunrong Zhu. Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.764618
|
| 7 |
Magdolna Dank, Dorottya Mühl, Magdolna Herold, Lilla Hornyák, Attila Marcell Szasz, Zoltan Herold. Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?. Journal of Clinical Medicine 2022; 11(16): 4815 doi: 10.3390/jcm11164815
|
| 8 |
Paul Sukwoo Yoon, Nuala Del Piccolo, Venktesh S. Shirure, Yushuan Peng, Amanda Kirane, Robert J. Canter, Ryan C. Fields, Steven C. George, Sepideh Gholami. Advances in Modeling the Immune Microenvironment of Colorectal Cancer. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.614300
|
| 9 |
Yankun Zhu, Mingyao Meng, Zongliu Hou, Wenju Wang, Lin Li, Aoran Guan, Ruotian Wang, Weiwei Tang, Fang Yang, Yiyi Zhao, Hui Gao, Hui Xie, Ruhong Li, Jing Tan. Impact of cytotoxic T lymphocytes immunotherapy on prognosis of colorectal cancer patients. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1122669
|
| 10 |
William H. Gmeiner. Fluoropyrimidine Modulation of the Anti-Tumor Immune Response―Prospects for Improved Colorectal Cancer Treatment. Cancers 2020; 12(6): 1641 doi: 10.3390/cancers12061641
|
| 11 |
Jun-Nan Guo, Ming-Qi Li, Shen-Hui Deng, Chen Chen, Yin Ni, Bin-Bin Cui, Yan-Long Liu. Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.640196
|
| 12 |
Gabriela Roliano, Juliana Azambuja, Veronica Brunetto, Hannah Butterfield, Antonio Kalil, Elizandra Braganhol. Colorectal Cancer and Purinergic Signalling: An Overview. Cancers 2022; 14(19): 4887 doi: 10.3390/cancers14194887
|
| 13 |
Ariel Hirschfeld, Daniel Gurell, Michael Har-Noy. Objective response after immune checkpoint inhibitors in a chemotherapy-refractory pMMR/MSS metastatic rectal cancer patient primed with experimental AlloStim® immunotherapy. Translational Medicine Communications 2024; 9(1) doi: 10.1186/s41231-024-00174-y
|
| 14 |
R. Bordonaro, A. Calvo, A. Auriemma, A. Hollebecque, G. Rubovszky, M.P. Saunders, Z. Pápai, G. Prager, A. Stein, T. André, G. Argilés, A. Cubillo, L. Dahan, J. Edeline, C. Leger, V. Cattan, R. Fougeray, N. Amellal, J. Tabernero. Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study. ESMO Open 2021; 6(5): 100270 doi: 10.1016/j.esmoop.2021.100270
|
| 15 |
Alyssa A. Leystra, Margie L. Clapper. Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer. Genes 2019; 10(11): 900 doi: 10.3390/genes10110900
|
| 16 |
Xuankun Yang, Jia Yan, Yahui Jiang, Yaxu Wang. An immune-related model based on INHBA, JAG2 and CCL19 to predict the prognoses of colon cancer patients. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02000-z
|
| 17 |
Joseph Tintelnot, Inka Ristow, Markus Sauer, Donjete Simnica, Christoph Schultheiß, Rebekka Scholz, Eray Goekkurt, Lisa von Wenserski, Edith Willscher, Lisa Paschold, Sylvie Lorenzen, Jorge Riera-Knorrenschild, Reinhard Depenbusch, Thomas J. Ettrich, Steffen Dörfel, Salah-Eddin Al-Batran, Meinolf Karthaus, Uwe Pelzer, Axel Hinke, Marcus Bauer, Chiara Massa, Barbara Seliger, Claudia Wickenhauser, Carsten Bokemeyer, Susanna Hegewisch-Becker, Mascha Binder, Alexander Stein. Translational analysis and final efficacy of the AVETUX trial – Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.993611
|
| 18 |
Minhan Jiang, Qi Shao, Joseph Slaughter, John Bischof. Irreversible Electroporation has More Synergistic Effect with Anti‐PD‐1 Immunotherapy than Thermal Ablation or Cryoablation, in a Colorectal Cancer Model. Advanced Therapeutics 2024; doi: 10.1002/adtp.202400068
|
| 19 |
Wei Zhang, Minmin Wu, Xucan Gao, Chiyu Ma, Huixuan Xu, Liewen Lin, Jingquan He, Wanxia Cai, Yafang Zhong, Donge Tang, Min Tang, Yong Dai. Multi-Platform-Based Analysis Characterizes Molecular Alterations of the Nucleus in Human Colorectal Cancer. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.796703
|
| 20 |
Javier Narbona, Luisa Hernández-Baraza, Rubén G. Gordo, Laura Sanz, Javier Lacadena. Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment. Biomolecules 2023; 13(7): 1042 doi: 10.3390/biom13071042
|
| 21 |
Hsin-Hua Hsieh, Chuan-Lin Chen, Hui-Wen Chan, Kwan-Hwa Chi, Chun-Yi Wu. Enhanced antitumour response of gold nanostar-mediated photothermal therapy in combination with immunotherapy in a mouse model of colon carcinoma. British Journal of Cancer 2024; 130(3): 406 doi: 10.1038/s41416-023-02537-y
|
| 22 |
Yulia Yu. Petukhova, Ekaterina V. Eliseeva, Vladimir I. Apanasevich, Antonina G. Petukhova, Anna V. Ovodova. Comparative pharmacoeconomic analysis of metastatic colorectal cancer treatment. Bulletin of the Russian Military Medical Academy 2021; 23(4): 213 doi: 10.17816/brmma61805
|
| 23 |
Ga-Young Park, Woo-Chang Son, Hong-Rae Lee, Eun-Kyoung Koh, Hyun Bon Kang, Jin Hoo Song, Dong Won Kim, YoungHee Kim, You-Soo Park. Comparison of Antitumor Effects of Combinations of Immune Checkpoint Inhibitors With Dendritic Cells Intratumorally Injected into Irradiated Mouse Adenocarcinoma. Journal of Immunotherapy 2024; doi: 10.1097/CJI.0000000000000548
|
| 24 |
Erika Durinikova, Kristi Buzo, Sabrina Arena. Preclinical models as patients’ avatars for precision medicine in colorectal cancer: past and future challenges. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01981-z
|
| 25 |
|
| 26 |
Ming Bai, Zhi-Guo Li, Yi Ba. Influence of KDR Genetic Variation on the Efficacy and Safety of Patients with Chemotherapy Refractory Metastatic CRC Who Received Apatinib Treatment. International Journal of General Medicine 2021; : 1041 doi: 10.2147/IJGM.S300968
|
| 27 |
Karthik Venkataraman, Tania Salehi, Robert P. Carroll. Immune Checkpoint Inhibitors in Recipients of Renal Allografts. Seminars in Nephrology 2024; 44(1): 151500 doi: 10.1016/j.semnephrol.2024.151500
|
| 28 |
Pei-Chia Su, Ching-Yu Chen, Min-Hua Yu, I.-Ying Kuo, Pei-Shan Yang, Ching-Hsuan Hsu, Ya-Chin Hou, Hsin-Ta Hsieh, Chih-Peng Chang, Yan-Shen Shan, Yi-Ching Wang. Fully human chitinase-3 like-1 monoclonal antibody inhibits tumor growth, fibrosis, angiogenesis, and immune cell remodeling in lung, pancreatic, and colorectal cancers. Biomedicine & Pharmacotherapy 2024; 176: 116825 doi: 10.1016/j.biopha.2024.116825
|
| 29 |
Yuan-Hong Xie, Ying-Xuan Chen, Jing-Yuan Fang. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-0116-z
|
| 30 |
Kyusang Hwang, Jin Hwan Yoon, Ji Hyun Lee, Sukmook Lee. Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers. Biomedicines 2021; 9(1): 39 doi: 10.3390/biomedicines9010039
|
| 31 |
Lindsey Carlsen, Kelsey E. Huntington, Wafik S. El-Deiry. Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. Cancers 2022; 14(4): 1028 doi: 10.3390/cancers14041028
|
| 32 |
Shuangqing Cao, Lei Zheng. Impacts of CD152 polymorphisms on cervical cancer susceptibility. Pathology - Research and Practice 2020; 216(8): 152918 doi: 10.1016/j.prp.2020.152918
|
| 33 |
Xianbin Kong, Qingbo Li, Dong Wang, Miao Wang, Fan Yang, Jingyan Meng. Mechanism of Qizhen decoction-mediated maturation of DC cells to activate the IL-12/JAK2/STAT4 pathway to sensitise PD-1 inhibitors in the treatment of colorectal cancer. Journal of Ethnopharmacology 2024; 320: 117399 doi: 10.1016/j.jep.2023.117399
|
| 34 |
Puneeth Guruprasad, Yong Gu Lee, Ki Hyun Kim, Marco Ruella. The current landscape of single-cell transcriptomics for cancer immunotherapy. Journal of Experimental Medicine 2021; 218(1) doi: 10.1084/jem.20201574
|
| 35 |
Dingde Ye, Yaping Liu, Guoqiang Li, Beicheng Sun, Jin Peng, Qingxiang Xu. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.766072
|
| 36 |
Julian L. Goggi, Siddesh V. Hartimath, Shivashankar Khanapur, Boominathan Ramasamy, Zan Feng Chin, Peter Cheng, Hui Xian Chin, You Yi Hwang, Edward G. Robins. Imaging Memory T-Cells Stratifies Response to Adjuvant Metformin Combined with αPD-1 Therapy. International Journal of Molecular Sciences 2022; 23(21): 12892 doi: 10.3390/ijms232112892
|
| 37 |
Javier Narbona, Rubén G. Gordo, Jaime Tomé-Amat, Javier Lacadena. A New Optimized Version of a Colorectal Cancer-Targeted Immunotoxin Based on a Non-Immunogenic Variant of the Ribotoxin α-Sarcin. Cancers 2023; 15(4): 1114 doi: 10.3390/cancers15041114
|
| 38 |
Neda Jabbari, Heidi L. Kenerson, Christopher Lausted, Xiaowei Yan, Changting Meng, Kevin M. Sullivan, Priyanka Baloni, Dani Bergey, Venu G. Pillarisetty, Leroy E. Hood, Raymond S. Yeung, Qiang Tian. Modulation of Immune Checkpoints by Chemotherapy in Human Colorectal Liver Metastases. Cell Reports Medicine 2020; 1(9): 100160 doi: 10.1016/j.xcrm.2020.100160
|
| 39 |
Ali Azadi, Alireza Golchini, Sina Delazar, Fatemeh Abarghooi Kahaki, Seyed Mohsen Dehnavi, Zahra Payandeh, Shirin Eyvazi. Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using bi-Specific Antibodies and Therapeutic Vaccines. Biological Procedures Online 2021; 23(1) doi: 10.1186/s12575-021-00147-7
|
| 40 |
Maria Rotundo, Vincenzo Bagnardi, Miryam Rotundo, Mario Comandè, Maria Zampino. PD‑1/PD‑L1 blockade, a novel strategy for targeting metastatic colorectal cancer: A systematic review and meta‑analysis of randomized trials. Oncology Letters 2022; 23(4) doi: 10.3892/ol.2022.13254
|
| 41 |
Xiao Albert Zhou, Jiadong Zhou, Long Zhao, Guihui Yu, Jun Zhan, Chanyi Shi, Ruoshi Yuan, Yan Wang, Changfeng Chen, Wenjia Zhang, Donghao Xu, Yingjiang Ye, Weibin Wang, Zhanlong Shen, Wei Wang, Jiadong Wang. KLHL22 maintains PD-1 homeostasis and prevents excessive T cell suppression. Proceedings of the National Academy of Sciences 2020; 117(45): 28239 doi: 10.1073/pnas.2004570117
|
| 42 |
Hao Ding, Huiwen Shi, Weifeng Chen, Zhisheng Liu, Zhi Yang, Xiaochuan Li, Zhichao Qiu, Hongqing Zhuo. Identification of Key Prognostic Alternative Splicing Events of Costimulatory
Molecule-Related Genes in Colon Cancer. Combinatorial Chemistry & High Throughput Screening 2024; 27(13): 1900 doi: 10.2174/0113862073249972231026060301
|
| 43 |
Ali Shamseddine, Youssef H. Zeidan, Ziad El Husseini, Malek Kreidieh, Monita Al Darazi, Rim Turfa, Joseph Kattan, Ibrahim Khalifeh, Deborah Mukherji, Sally Temraz, Kholoud Alqasem, Rula Amarin, Tala Al Awabdeh, Samer Deeba, Faek Jamali, Issa Mohamad, Mousa Elkhaldi, Faiez Daoud, Mahmoud Al Masri, Ali Dabous, Ahmad Hushki, Omar Jaber, Maya Charafeddine, Fady Geara. Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma. Radiation Oncology 2020; 15(1) doi: 10.1186/s13014-020-01673-6
|
| 44 |
Ga-Young Lee, Jin-Seok Lee, Chang-Gue Son, Nam-Hun Lee. Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines. Chinese Journal of Integrative Medicine 2021; 27(7): 551 doi: 10.1007/s11655-020-3425-8
|
| 45 |
Nagwa M. Abdelazeem, Shaimaa A. Gouhar, Cinderella A. Fahmy, Zeinab A. Elshahid, Marwa El-Hussieny. Evaluation of newly synthesized 2-(thiophen-2-yl)-1H-indole derivatives as anticancer agents against HCT-116 cell proliferation via cell cycle arrest and down regulation of miR-25. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68815-8
|